Each unit increase in the relative expression of the EIF2S3, POLDIP2, and RNF4 genes showed protective effects, with odds of having lung cancer decreased by 78%, 84%, and 78%, respectively. The gene discussed is POLDIP2; the disease is lung carcinoma.